Using Navigating Cancer’s Health Tracker electronic patient reported outcome software, the Texas Two Step Study found a substantial impact on quality of care and associated costs for metastatic cancer patients:
While there has been extensive research demonstrating racial disparities in pain reporting and management, this is, to our knowledge, the first published research leveraging oncology electronic patient-reported outcomes (ePROs) and nursing care management intervention data that further demonstrate disparities at the point-of-care.
Digital health solutions can be used to support the cancer patient journey and we demonstrated high utilization in an array of sociodemographic variables in our population. However, tools designed and implemented with different populations in mind to reduce staff burden and lessen the digital divide should be further explored.
Enhance clinical care through the development of products for cancer patients
Contribute to clinical research incorporating patient reported outcomes (PROs) data.
Power population health analytics for identifying at-risk patients and providing timely interventions.
There is rising interest to implement electronic patient-reported outcomes (ePRO) for symptom monitoring to enhance quality of cancer care. Step 1 of the Texas Two-Step Study demonstrated successful implementation of an ePRO system in >200 sites of service of a large community oncology practice. We now report step 2 of this study which evaluates the impact of ePROs on outcomes among patients enrolled in CMS’ Oncology Care Model (OCM) program.
Debra Patt M.D., Ph.D., MBA
While there has been extensive research demonstrating racial disparities in pain reporting and management, this is, to our knowledge, the first published research leveraging oncology electronic patient-reported outcomes (ePROs) and nursing care management intervention data that further demonstrate disparities at the point-of-care.
Digital health solutions (DHS) allow for enhanced remote communication between patients and clinical staff and the COVID-19 pandemic has brought these tools to the forefront of care delivery. Once adopted, barriers to adequate utilization still exist. Given the important need to decrease digital divides, and the diversity of patients and care settings across our clinic’s 220 sites of service, we sought to understand how utilization of oncology DHS may be limited among certain populations.
Debra A. Patt, Amila Meera Patel, Kathryn Elizabeth Hudson, Susan Marie Escudier, Holly Books, Sydney Townsend, Arun Bhardwaj, Bhanu Kaushik, Ben Pearson, Christopher Bays, Ethan Basch
There is a priority to accelerate the delivery of digital health solutions (DHS) to provide patients with enhanced means for accessing care, but lack of understanding of their utility in certain populations. There are concerns that equitable adoption translate into disparities. We sought to implement a portfolio of DHS across a large practice and characterize engagement across populations to enhance clinical informatics solutions that support care delivery.
Amila Meera Patel, Arun Bhardwaj, Ethan Basch, Kathryn Elizabeth Hudson, Susan Marie Escudier, Holly Books, Bhanu Kaushik, Ben Pearson, Christopher Bays, Sydney Townsend, Debra A. Patt
Genentech and Navigating Cancer researchers analyzed data from more than 200K people living with cancer, found that most communities of color have limited access and online communication with oncologists on digital health platforms.
In a study of real-world ePRO implementation, Texas Oncology targeted cancer patients initiating systemic therapy to enroll in the Health Tracker ePRO digital monitoring program. The process included patient screening, introduction to the program, enrollment, initiation, observation, and intervention through the triage board workflow. There was a 65% ePRO compliance rate in the 4375 patients enrolled, as well as high participation rates among patients 65 years and older, those completing ePROs via text message, and patients on oral treatment.